Looking to know more about immunogenecity challenges in gene therapy and the role of complement system? Dr. Anna Majowicz- Preclinical Immunology Lead at Spark Therapeutics- provides valuable insights into how investigating complement system can aid to tackle challenges in AAV-mediated gene therapy.
Read more about the potential use of complement biomarkers in managing immune responses to AAV vectors in this Editorial Article. Download yours by filling out the form.
